Skip to main content
. 2019 Apr 22;20(8):1958. doi: 10.3390/ijms20081958

Table A1.

Differentially expressed genes in idiopathic pulmonary fibrosis (IPF) fibroblasts treated with epigallocatechin gallate (EGCG) versus water (control).

Official Gene Symbol FPKM Ratio
(EGCG/Control)
Log2(ratio) p-Value q-Value *
EGCG Control
PCSK9 0.85 0.09 9.65 3.27 0.0003 0.0846
HMGCS1 441.43 57.81 7.64 2.93 0.0001 0.0268
BTBD7 7.42 1.07 6.96 2.80 0.0001 0.0268
CTIF 5.12 0.89 5.75 2.52 0.0003 0.0846
FAM120B 2.44 0.43 5.64 2.50 0.0007 0.1650
PLA2G3 1.29 0.24 5.29 2.40 0.0005 0.1250
FABP3 117.28 23.12 5.07 2.34 0.0001 0.0268
VPS53 10.80 2.16 4.99 2.32 0.0001 0.0268
HSPB3 5.34 1.12 4.76 2.25 0.0011 0.2481
MVD 96.80 22.27 4.35 2.12 0.0001 0.0268
TMEM97 140.13 32.98 4.25 2.09 0.0001 0.0268
MSMO1 224.89 55.13 4.08 2.03 0.0001 0.0268
HMGCR 136.04 34.55 3.94 1.98 0.0001 0.0268
ARHGEF5 3.48 0.90 3.86 1.95 0.0001 0.0268
HSD17B7 11.98 3.12 3.85 1.94 0.0003 0.0973
PALMD 3.68 0.96 3.82 1.93 0.0004 0.1047
DHCR7 84.31 22.39 3.76 1.91 0.0001 0.0268
IDI1 185.79 51.74 3.59 1.84 0.0003 0.0846
CYP51A1 329.34 94.32 3.49 1.80 0.0001 0.0268
ACSS2 25.91 7.69 3.37 1.75 0.0001 0.0268
DMKN 2.32 0.71 3.28 1.71 0.0001 0.0268
SLC40A1 7.87 2.43 3.24 1.70 0.0003 0.0846
SQLE 108.28 34.77 3.11 1.64 0.0001 0.0268
FBXO32 5.71 1.85 3.08 1.62 0.0005 0.1319
FDFT1 206.04 69.04 2.98 1.58 0.0001 0.0268
BIRC3 12.03 4.07 2.95 1.56 0.0003 0.0973
RRAD 4.19 1.43 2.94 1.55 0.0010 0.2174
ITGB8 6.31 2.17 2.91 1.54 0.0001 0.0486
FDPS 260.06 91.77 2.83 1.50 0.0001 0.0268
SCD 377.97 134.01 2.82 1.50 0.0001 0.0486
INSIG1 268.58 95.40 2.82 1.49 0.0001 0.0268
LSS 129.93 46.81 2.78 1.47 0.0002 0.0798
LBH 128.19 46.39 2.76 1.47 0.0001 0.0268
RPS17 60.77 22.54 2.70 1.43 0.0004 0.1047
NTN4 12.06 4.72 2.56 1.35 0.0005 0.1319
CEMIP 216.43 85.86 2.52 1.33 0.0005 0.1250
LMOD1 15.53 6.33 2.46 1.30 0.0001 0.0268
NSDHL 53.96 22.04 2.45 1.29 0.0001 0.0486
SC5D 93.06 38.02 2.45 1.29 0.0003 0.0846
GABARAPL1 20.49 8.74 2.34 1.23 0.0002 0.0798
FRY 6.83 3.06 2.23 1.16 0.0003 0.0846
PDE5A 278.27 125.88 2.21 1.14 0.0007 0.1556
BHLHE40 16.48 7.50 2.20 1.13 0.0006 0.1482
QPRT 12.85 5.85 2.20 1.13 0.0005 0.1250
DHCR24 151.61 73.96 2.05 1.04 0.0008 0.1742
SEMA7A 26.51 54.97 0.48 -1.05 0.0004 0.1174
MT2A 352.79 738.65 0.48 -1.07 0.0004 0.1047
EGR1 17.36 36.40 0.48 -1.07 0.0006 0.1426
STC1 41.69 87.70 0.48 -1.07 0.0007 0.1556
SERPINB2 131.57 286.07 0.46 -1.12 0.0002 0.0798
PLXNA4 2.83 7.07 0.40 -1.32 0.0005 0.1319
SQSTM1 11.91 36.40 0.33 -1.61 0.0001 0.0268
SORBS2 0.12 0.41 0.30 -1.73 0.0004 0.1047
ESM1 10.28 45.34 0.23 -2.14 0.0001 0.0268
THBD 3.13 14.37 0.22 -2.20 0.0001 0.0268
MYLIP 0.61 2.91 0.21 -2.24 0.0006 0.1482
RGPD6 0.57 2.99 0.19 -2.38 0.0002 0.0798
TOP3A 0.42 2.21 0.19 -2.40 0.0002 0.0798
ABCA1 2.09 13.21 0.16 -2.66 0.0001 0.0268
IVL 0.13 1.03 0.12 -3.01 0.0001 0.0268
ITPK1 0.85 7.50 0.11 -3.14 0.0001 0.0268

* p-values adjusted with false discovery rate using the method by Benjamini et al. IPF, idiopathic pulmonary fibrosis; EGCG, epigallocatechin gallate; FPKM, fragments per kilobase of transcript per million mapped reads.